drugset / Trial / NCT01690975
Benzonatate Dose Tolerance Study
RandomizedCrossoverTriple-blindBasic science
Summary
This is a single-center, randomized, third party blind, placebo controlled, dose escalation study of benzonatate following single dose administration. The primary oobjective is to assess the safety and tolerability of increasing oral doses of benzonatate following single dose administration in healthy male and female subjects.
Timeline
- Start
- 2012-07
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benzonatate | Small molecule | 400 mg | Oral |
| Subject | Benzonatate | Small molecule | 600 mg | Oral |
Indications
No indication recorded.